Alcohol Addiction
Understanding Alcohol Use Disorder: Science, Health Impacts, and the Path to Recovery
Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician, Phuket Island Rehab
Alcohol addiction, clinically known as alcohol use disorder (AUD), is a chronic medical condition characterised by an impaired ability to stop or control alcohol use despite adverse consequences. The DSM-5 classifies AUD using 11 diagnostic criteria across three severity levels: mild, moderate, and severe. It is not a failure of willpower. It involves measurable neuroadaptive changes in the brain’s reward, stress, and executive function systems, making professional treatment essential for recovery.
Clinical Insight:
“In my practice at Phuket Island Rehab, I consistently observe that patients arriving for alcohol-related care share a common experience: they initially believed they could manage their drinking on their own, and they are often surprised to learn how profoundly alcohol has altered their neurochemistry. By the time they reach our facility, the neurological and medical consequences of chronic alcohol use are already well established, which underscores the importance of early intervention and medically supervised treatment.” — Dr. Ponlawat Pitsuwan, Physician
What Is Alcohol Use Disorder?
Alcohol use disorder (AUD) is the clinical term for a pattern of alcohol consumption that leads to significant impairment or distress. The DSM-5, published by the American Psychiatric Association, defines AUD through 11 diagnostic criteria evaluated over a 12-month period. These criteria span loss of control, social impairment, risky use, and pharmacological indicators such as tolerance and withdrawal. Severity is determined by how many criteria a person meets: two to three indicates mild AUD, four to five indicates moderate, and six or more indicates severe. The NIAAA estimates that approximately 28.6 million adults in the United States meet criteria for AUD.
How Alcohol Changes the Brain
The Koob-Volkow three-stage model, developed at the National Institutes of Health, provides the most widely accepted framework for explaining the neuroscience of addiction. During the binge and intoxication stage, alcohol triggers a dopamine surge in the nucleus accumbens, producing euphoria. It enhances GABA-A receptors (the brain’s inhibitory system) while suppressing NMDA glutamate receptors (the excitatory system), creating alcohol’s depressant effects.
With repeated use, the brain recalibrates: GABA-A receptors downregulate and NMDA receptors upregulate, forming the biological basis of tolerance. When alcohol is removed, this imbalance drives the withdrawal and negative affect stage, where stress chemicals including corticotropin-releasing factor (CRF) flood the extended amygdala, producing anxiety and dysphoria. The individual drinks to feel normal rather than to feel good.
In the preoccupation and anticipation stage, impaired prefrontal cortex function weakens impulse control, creating persistent cravings. These three stages form a self-reinforcing cycle that becomes increasingly difficult to break without professional intervention.
Health Consequences of Chronic Alcohol Use
Warning:
Chronic alcohol use damages virtually every organ system. The harm is cumulative and often develops silently over years before symptoms appear.
| Body System | Condition | Mechanism |
|---|---|---|
| Liver | Steatosis → hepatitis → cirrhosis | CYP2E1-generated reactive oxygen species |
| Brain / nervous system | Wernicke-Korsakoff syndrome, peripheral neuropathy | Thiamine deficiency; direct neurotoxicity |
| Cardiovascular | Cardiomyopathy, arrhythmias, hypertension | Direct myocardial toxicity |
| Cancer | Breast, head/neck, oesophageal, colorectal, liver | Acetaldehyde-DNA adducts; ALDH2 polymorphism |
| Pancreas | Acute and chronic pancreatitis | Premature digestive enzyme activation |
The International Agency for Research on Cancer (IARC) classifies alcohol as a Group 1 carcinogen. The primary mechanism involves acetaldehyde, a toxic metabolite that binds to DNA and interferes with cell replication. Individuals carrying the ALDH2*2 genetic variant accumulate higher acetaldehyde levels and face elevated cancer risk.
Treatment Approaches
Key Point:
Effective treatment combines medical, pharmacological, and behavioural interventions tailored to the individual. No single approach works for everyone.
Medical detoxification is often the necessary first step for moderate to severe AUD. Alcohol withdrawal can produce life-threatening symptoms including seizures and delirium tremens. Supervised withdrawal management uses benzodiazepines guided by the CIWA-Ar scale. Learn more on our alcohol withdrawal and medical detox pages.
Medications including naltrexone (a mu-opioid receptor antagonist that blocks alcohol-induced dopamine release), acamprosate (which restores NMDA/GABA balance), and disulfiram (which causes acetaldehyde accumulation if alcohol is consumed) have demonstrated efficacy in supporting recovery.
Behavioural therapies such as cognitive behavioural therapy (CBT) and motivational interviewing (MI) address the psychological dimensions of addiction. CBT targets thought patterns that drive drinking, while MI helps individuals articulate their own reasons for change.
Residential rehabilitation offers the most comprehensive care for severe AUD. At Phuket Island Rehab, our programme combines medical detox, evidence-based therapies, holistic wellness, and aftercare planning. Visit our rehab programme or read about alcohol recovery and rehab for more details.
When Drinking Has Become More Than Occasional
Many people with AUD do not fit the stereotypical image of addiction. They hold jobs, maintain relationships, and appear to function normally. If you find yourself drinking more than intended, unable to cut back, or if people close to you have expressed concern, these are signals worth taking seriously. AUD is a medical condition with identifiable biological mechanisms, and it responds to treatment. For a detailed look at warning signs, visit our page on signs of alcohol addiction.
Support:
988 Suicide and Crisis Lifeline (US): call or text 988
Crisis Text Line: text HOME to 741741
Befrienders Worldwide: befrienders.org
Phuket Island Rehab: phuketislandrehab.com
Summary
Alcohol addiction is a chronic medical condition rooted in measurable changes to brain chemistry. The DSM-5 provides a clear diagnostic framework, and the Koob-Volkow model explains how alcohol hijacks the brain’s reward, stress, and executive control systems. Health consequences extend across the liver, brain, cardiovascular system, pancreas, and cancer risk. Recovery is achievable through integrated treatment combining medical detox, pharmacotherapy, behavioural therapy, and residential rehabilitation.
“Recovery from alcohol addiction is a medical process, not a moral one. When we treat alcohol use disorder with the same clinical rigour that we apply to any other chronic disease, patients achieve outcomes that would have seemed impossible at their lowest point. The science of addiction medicine has given us effective tools; the key is ensuring that people who need them can access them without shame or delay.” — Dr. Ponlawat Pitsuwan, Physician
Frequently Asked Questions
Is alcohol addiction a disease?
Yes. Alcohol addiction is recognised as a chronic brain disease by the American Medical Association, the NIAAA, and the WHO. Brain imaging research has demonstrated that chronic alcohol use produces lasting changes in brain structure and function, particularly in reward, stress, and executive control circuits. Like diabetes or hypertension, it requires ongoing management, and relapse is considered part of the disease course rather than a treatment failure.
How is alcohol use disorder diagnosed?
AUD is diagnosed by a healthcare professional using the 11 DSM-5 criteria evaluated over the past 12 months. These criteria cover loss of control, continued use despite harm, tolerance, withdrawal, and impairment of daily functioning. Severity is classified by the number of criteria met: mild (two to three), moderate (four to five), or severe (six or more). Screening tools such as the AUDIT (Alcohol Use Disorders Identification Test) and CAGE questionnaire are often used in primary care to identify individuals who may benefit from full clinical assessment.
Can you recover from alcohol addiction?
Recovery from alcohol addiction is absolutely possible. Research consistently shows that a combination of medical treatment, behavioural therapy, and social support produces the best outcomes. Medications such as naltrexone and acamprosate reduce cravings and support abstinence, while therapies including CBT and motivational interviewing address the psychological dimensions. The most important factor is accessing professional treatment and building a sustainable support network.
Is alcoholism genetic?
Genetics account for approximately 40 to 60 percent of AUD risk. Variants in the ALDH2 and ADH1B genes directly influence alcohol metabolism and affect susceptibility. However, genetics alone do not determine outcomes. Environmental factors, including childhood experiences, peer influences, and co-occurring mental health conditions, interact with genetic predisposition. Having a family history increases risk but does not make AUD inevitable.
What is the difference between alcohol abuse and alcohol dependence?
“Alcohol abuse” and “alcohol dependence” were separate diagnostic categories in the older DSM-IV system. The DSM-5 (2013) eliminated this distinction and replaced both with a single diagnosis, alcohol use disorder, on a severity spectrum. This change reflects research showing that problematic alcohol use exists on a continuum and that the old two-category system could lead to underdiagnosis.
How does alcohol addiction affect the brain?
Alcohol addiction produces measurable changes across three brain systems. In the reward system, chronic use reduces natural dopamine signalling, so the individual experiences less pleasure from everyday activities. In the stress system (extended amygdala), withdrawal triggers stress chemicals that produce anxiety and emotional pain driving further drinking. In the prefrontal cortex, chronic exposure weakens executive function, impairing the ability to resist cravings. These three domains correspond to the Koob-Volkow model’s binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation stages.
Sources
1. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Understanding Alcohol Use Disorder. niaaa.nih.gov
2. World Health Organization (WHO). Global Status Report on Alcohol and Health. who.int
3. International Agency for Research on Cancer (IARC). Monographs on Carcinogenic Risks: Alcohol Drinking. monographs.iarc.who.int
4. Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760-773.
5. American Psychiatric Association. DSM-5. Washington, DC: 2013.
alcohol use disorder, DSM-5, GABA-A receptor, NMDA receptor, dopamine, nucleus accumbens, Koob-Volkow model, CYP2E1, ALDH2, ALDH2*2, acetaldehyde, IARC Group 1, naltrexone, acamprosate, disulfiram, CIWA-Ar, Wernicke-Korsakoff syndrome, CBT, motivational interviewing, NIAAA, Phuket Island Rehab